{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:27:22Z","timestamp":1791095242200,"version":"4.1.0"},"reference-count":29,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2002,1,12]],"date-time":"2002-01-12T00:00:00Z","timestamp":1010793600000},"content-version":"vor","delay-in-days":164,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Experimental Allergy"],"published-print":{"date-parts":[[2001,8]]},"abstract":"<jats:p><jats:bold>Background<\/jats:bold> Venom immunotherapy (VIT) is an efficient treatment of hymenoptera venom allergy. The mechanism of VIT is based on the induction of tolerance of allergen\u2010specific Th2 cells. The mechanisms of this T cell modulation are unknown, and could depend on cytokines produced by other cell types such as interleukin (IL)\u201012, tumour necrosis factor (TNF)\u2010\u03b1 and IL\u201010 by monocytes.<\/jats:p><jats:p><jats:bold>Objective<\/jats:bold> To assess if VIT modifies the monocyte production of IL\u201012, TNF\u2010\u03b1 and IL\u201010 during the 45 first days of treatment.<\/jats:p><jats:p><jats:bold>Methods<\/jats:bold> Fourteen patients and seven controls were included. Blood samples were taken once in controls and at day (D)1, D30 and D45 of VIT in patients. Monocytes were isolated, cultured with and without lipopolysaccharide (LPS), and the culture supernatant was harvested. IL\u201010, IL\u201012 and TNF\u2010\u03b1 were assayed in supernatants by ELISA.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold> Baseline cytokine levels were not statistically different between patients and controls. During treatment, an increase of spontaneous monocyte production of IL\u201012 and TNF\u2010\u03b1 was observed at D15 and D45. The production of IL\u201010 increased at D15 and D45 but not significantly. After LPS\u2010stimulation, IL\u201012, TNF\u2010\u03b1 and IL\u201010 monocyte production was not modified by VIT.<\/jats:p><jats:p><jats:bold>Conclusion<\/jats:bold> VIT induces a monocyte activation characterized by a delayed overproduction of IL\u201012 and TNF\u2010\u03b1. These cytokines could be relevant to the inhibition of Th2 cells during VIT. Therefore, VIT\u2010induced tolerance could depend not only on the specific action of venom antigens on T cells, but also on a secondary non\u2010specific action of monocytes.<\/jats:p>","DOI":"10.1046\/j.1365-2222.2001.01171.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T09:48:39Z","timestamp":1047376119000},"page":"1303-1309","source":"Crossref","is-referenced-by-count":27,"title":["Venom immunotherapy induces monocyte activation"],"prefix":"10.1111","volume":"31","author":[{"given":"A.","family":"Magnan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Marin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"M\u00e9ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Birnbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Romanet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Bongrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Vervloet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,1,12]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(98)70271-4"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(98)70079-X"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1398-9995.2000.00120.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI2250"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.1998-47-1.00383.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118963"},{"key":"e_1_2_6_8_2","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1084\/jem.178.6.2123","article-title":"Allergen immunotherapy decreases interleukin\u20104 production in CD4+ T cells from allergic individuals","volume":"178","author":"Secrist H","year":"1993","journal-title":"J Exp Med"},{"key":"e_1_2_6_9_2","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.4049\/jimmunol.154.8.4187","article-title":"Bee venom immunotherapy results in decrease of IL\u20104 and IL\u20105 and increase of IFN\u2010\u03b3 secretion in specific allergen\u2010stimulated T cell cultures","volume":"154","author":"Jutel M","year":"1995","journal-title":"J Immunol"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1995.tb00025.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1996.506585.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116633"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(96)70205-1"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(97)70081-2"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(99)70509-9"},{"key":"e_1_2_6_16_2","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1084\/jem.181.3.1081","article-title":"Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen\u2010presenting cell type","volume":"181","author":"Secrist H","year":"1995","journal-title":"J Exp Med"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1998.tb03858.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.4049\/jimmunol.138.6.1786","article-title":"Immunoregulatory activity of recombinant human tumor necrosis factor (TNF) \u2010alpha: induction of TNF receptors on human T cells and TNF\u2010alpha\u2010mediated enhancement of T cell responses","volume":"138","author":"Scheurich P","year":"1987","journal-title":"J Immunol"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1993.tb00886.x"},{"key":"e_1_2_6_20_2","first-page":"5247","article-title":"Non specific binding by macrophages. existence of different adhesive mechanisms and modulation by metabolic inhibitor","volume":"41","author":"Benoliel AM","year":"1980","journal-title":"Immunology"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80413-6"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.153.2.8564093"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(97)70106-4"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.2.646.bloodjournal862646"},{"key":"e_1_2_6_25_2","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.4049\/jimmunol.162.9.5224","article-title":"IL\u20104 inhibits the production of TNF\u2010alpha and IL\u201012 by STAT6\u2010dependent and \u2010independent mechanisms","volume":"162","author":"Levings MK","year":"1999","journal-title":"J Immunol"},{"key":"e_1_2_6_26_2","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.4049\/jimmunol.162.5.2748","article-title":"Lymphocyte Activation Gene\u20103, a MHC class II ligand expressed on activated T cells, stimulates TNF\u2010\u03b1 and IL\u201012 production by monocytes and dentritic cells","volume":"162","author":"Avice MN","year":"1999","journal-title":"J Immunol"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/146.3.768"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.1999.00365.x"},{"key":"e_1_2_6_29_2","first-page":"1164","article-title":"Interleukin\u201010: an anti\u2010inflammatory cytokine with therapeutic potential","volume":"29","author":"Pretolani M","year":"1999","journal-title":"Immunol Today"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830270513"}],"container-title":["Clinical &amp; Experimental Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2222.2001.01171.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2222.2001.01171.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2222.2001.01171.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T20:37:30Z","timestamp":1697575050000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2222.2001.01171.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2001,8]]}},"alternative-id":["10.1046\/j.1365-2222.2001.01171.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2222.2001.01171.x","archive":["Portico"],"relation":{},"ISSN":["0954-7894","1365-2222"],"issn-type":[{"value":"0954-7894","type":"print"},{"value":"1365-2222","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,8]]}}}